| Multi-centre, randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of the pain relieving effect of Dronabinol in patients with multiple sclerosis associated with central neuropathic pain | Multi-centre, randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of the pain relieving effect of Dronabinol in patients with multiple sclerosis associated with central neuropathic pain | EUCTR2006-004255-38-AT |
| Efficacy Trial of Oral Tetrahydrocannabinol in Patients With Fibromyalgia | A Randomized, Double-blind, Placebo-controlled Trial of Oral Tetrahydrocannabinol (?-9-THC) in Patients With Fibromyalgia | NCT01149018 |
| Placebo controlled fMRT assessment of the effects of the cannabinoid receptor agonist dronabinol (THC) on pain associated brain activation | Placebo controlled fMRT assessment of the effects of the cannabinoid receptor agonist dronabinol (THC) on pain associated brain activation | DRKS00000315 |
| Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoids (Tetrahydrocannabinol and Cannabidiol) | Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoid Combination (?9 -Tetrahydrocannabinol (THC) and Cannabidiol (CBD) In 1:1 Ratio) | NCT01893424 |
| Safety and Tolerability of Namisol in the Elderly | Safety and Tolerability of Oral Namisol®, a Tablet Containing Delta-9-Tetrahydrocannabinol, in Elderly Subjects: A Randomized Controlled Trial | NCT01740960 |
| THC in behavioural problems and pain in dementia | Efficacy and safety of delta-9-tetrahydrocannabinol (delta-THC) in behavioural disturbances and pain in dementia - delta-THC in dementia | EUCTR2011-005289-39-NL |
| Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study) | Low Dose Administration of Delta9-Tetrahydrocannabinol for the Prevention of Hyperalgesia and Chronic Pain in Patients With Acute Complex Regional Pain Syndrome (CRPS) of the Upper Limb | NCT00377468 |
| Modulaton of stress analgesia with tetrahydrocannabinol or cannabidiol | Modulaton of stress analgesia with tetrahydrocannabinol or cannabidiol - LOGIN-TS4 | DRKS00005442 |
| A study that evaluates the effectiveness of oral combined THC/CBD for people with advanced cancer experiencing a range of symptoms. | Oral Medicinal cannabinoids to Relieve Symptom Burden in the Palliative care of Patients with Advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) | ACTRN12619000037101 |
| Effects of THC and CBD on Human Episodic Memory Function | Effects of D-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) on Human Episodic Memory Function | NCT02291562 |
| Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC) | Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC): Effectiveness, Side Effects and Neurobiological Changes | NCT03215940 |
| A Randomised, Double Blind, Placebo-Controlled Trial of Medicinal Cannabis in Adults with Tourette's Syndrome | A Randomised, Double Blind, Placebo-Controlled, Crossover Trial of Tetrahydrocannabinol and Cannabidiol for the treatment of Tourette’s Syndrome | ACTRN12618000545268 |
| Excretion and side effects for tetrahydrocannabinol and cannabidiol (Sativex) among patients with chronic kidney disease and patients on dialysis. | Pharmacokinetics and side effects for tetrahydrocannabinol and cannabidiol (Sativex) among patients with chronic kidney disease and patients on dialysis. - PK cannabinoids | EUCTR2019-002786-35-DK |
| Do blood, saliva and urine levels of THC and cannabidiol (chemicals found in cannabis) relate to their effects on personality and perception | Tissue Levels of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) and Effects on Perception and Personality in healthy volunteers | ACTRN12621000142831 |
| Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg Vs Placebo As Adjuvant Treatment in Chronic Migraine - | Randomized, Double Blind Clinical Trial to Study the Effect of Cannabidiol (CBD) 133mg + Cannabigerol (CBG) 66mg + Tetrahydrocannabinol (THC) 4mg a Day As Adjunctive Therapy in the Treatment of Chronic Migraine - CAMTREA TRIAL | NCT04989413 |
| Does Cannabidiol Attenuate the Acute Effects of ?9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study | Does Cannabidiol Attenuate the Acute Effects of ?9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study | NCT04605393 |
| Responses to Marijuana-Related Cues Versus Neutral Cues in Adults Taking Tetrahydrocannabinol (THC) - 2 | Cue Reactivity Model for Assessing Pharmacologic Intervention in Treatment of Cannabis Use Disorders (Study 2) | NCT00218504 |
| A Study On The Efficacy Of Delta-9-Tetrahydrocannabinol (Dronabinol) In Renal Itch | A Study On The Efficacy Of Delta-9-Tetrahydrocannabinol (Dronabinol) In Renal Itch | EUCTR2005-000817-37-GB |
| Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) | Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) | NCT02291536 |
| Effects of Dronabinol in Opioid Maintained Patients | The Effects of Dronabinol in Opioid-Related Outcomes | NCT04025359 |
| Treatment of Patients Suffering from Tumour Cachexia with Dronabinol (tetrahydrocannabinol) or PlaceboComparison of individually optimised dosages in a double blind, randomised parallel design - Dronabinol for tumour cachexia | Treatment of Patients Suffering from Tumour Cachexia with Dronabinol (tetrahydrocannabinol) or PlaceboComparison of individually optimised dosages in a double blind, randomised parallel design - Dronabinol for tumour cachexia | EUCTR2007-002968-10-AT |
| Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer | Randomized, Double-Blind, Placebo-Controlled Trial of Palonosetron/Dexamethasone With or Without Dronabinol for the Prevention of Chemotherapy-Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy | NCT00553059 |
| Ph1 Marinol Interaction Study - Part 2 - 1 | Phase 1, Pilot Study to Examine the Cardiovascular Effects of Smoked Marijuana, Interactions With Oral Dronabinol, and Effects of Dronabinol on Withdrawal in Marijuana Dependent Volunteers | NCT00490269 |
| Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal | A Phase II Double-Blind Placebo-Controlled Trial of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal | NCT00480441 |
| Treatment of Patients Suffering from Nausea/Vomiting with Dronabinol (tetrahydrocannabinol)Comparsion of three dosages versus standard therapy in a cross-over design | Treatment of Patients Suffering from Nausea/Vomiting with Dronabinol (tetrahydrocannabinol)Comparsion of three dosages versus standard therapy in a cross-over design | EUCTR2007-000444-27-AT |
| Ph1 Marinol Interaction Study - Part 1 - 1 | Phase 1, Pilot Study to Examine the Cardiovascular Effects of Smoked Marijuana, Interactions With Oral Dronabinol, and Effects of Dronabinol on Withdrawal in Marijuana Dependent Volunteers | NCT00438139 |
| Efficacy of Dronabinol for the Treatment of Cervical Dystonia | Phase II, Double Blind, Randomized, Placebo Controlled Trial of Dronabinol for the Treatment of Cervical Dystonia | NCT00418925 |
| Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study | A Double-blind, Randomized, Placebo Controlled Clinical Trial to Evaluate the Efficacy of Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study | NCT00316563 |
| A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas | A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas | NCT00314808 |
| Dronabinol Treatment for Marijuana Addiction | A Randomized, Double-Blind, Placebo-Controlled Study of Dronabinol in the Treatment of Marijuana Addiction | NCT00217971 |
| Study to Evaluate the Efficacy of Dronabinol (Marinol) as Add-On Therapy for Patients on Opioids for Chronic Pain | A Randomized Controlled Clinical Trial of Dronabinol (Marinol) vs Placebo as Add-on Therapy For Patients on Opioids for Chronic Pain | NCT00153192 |
| Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache | A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Efficacy, Safety and Tolerability Study of Dronabinol MDI in the Acute Treatment of Migraine Headache | NCT00123201 |
| A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome | A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome | NCT00000737 |
| Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease | Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease | NCT03978156 |
| Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer | Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Clinical Trial to Investigate the Efficacy and Safety of Dronabinol in the Improvement of ChemOthErapy-induced and Tumor-Related Symptoms in Patients With Locally Advanced or Metastatic Pancreatic Cancer During First-line Chemotherapy (DIsCOvER) | NCT03984214 |
| Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital | A Randomized, Double-Blind, Placebo-Controlled, Parallel Groups Study to Explore The Safety And Therapeutic Potential Of Cannabinoids As An Adjunct For Reducing Pain (Carp)- TCH | NCT06834997 |
| The Safety, Tolerability and Efficacy of Dronabinol, for the Treatment of Nausea and Vomiting in Familial Dysautonomia | The Safety , Tolerability and Efficacy of Dronabinol, a Synthetic Endocannabinoid Receptor Agonist, for the Treatment of Nausea and Vomiting in Patients With Familial Dysautonomia | NCT02608931 |
| Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease | Pilot Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease | NCT02792257 |
| Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I | Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I | NCT02811510 |
| Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study | Effects of THC on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study | NCT03008005 |
| Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome | Examining the Efficacy of a Therapeutic Combination of Dronabinol (Synthetic ?9-tetrahydracannabinol) and Palmitoylethanolamide for Tourette Syndrome | NCT03066193 |
| Tetrahydrocannabinol (THC) and Sleep | Effect of Tetrahydrocannabinol (THC) on Sleep in Humans | NCT03560934 |
| DRonabinol Treatment of OSA | Targeted Treatment of Obstructive Sleep Apnea With Dronabinol: Proof of Concept and Phase II Clinical Trial | NCT06477952 |
| Reducing Breathlessness With Dronabinol in COPD Patients | BONG: Reducing Severe Breathlessness With Dronabinol in the Severe and Very Severe Chronic Obstructive Pulmonary Disease Patient Group - A Randomized, Double-Blind, Placebo-Controlled, Crossover Study | NCT06473701 |
| Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting | A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Efficacy Study of Oral Dronabinol Alone and in Combination With Ondansetron Versus Ondansetron Alone in Subjects With Delayed Chemotherapy-Induced Nausea and Vomiting | NCT00642512 |
| Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting | A Double-Blind, Randomized, Parallel-Group, Pilot Study of Oral Dronabinol Versus Placebo in the Treatment or Prevention of Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting | NCT00642499 |
| Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers | Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers | NCT00743119 |
| Tetrahydrocannabinol for cancer-related anorexia | Phase IIb double-blind, placebo-controlled study of sublingual delta-9-tetrahydrocannabinol (Hypera®) for anorexia in people with advanced cancer | ACTRN12619000491167 |
| Delta-9-tetrahydrocannabinol concentrations in hair after oral administration of dronabinol | Delta-9-tetrahydrocannabinol concentrations in hair after oral administration of dronabinol | DRKS00006148 |
| Modulation of THC Effects by CBD: a Dose-ranging Study | Modulation of ?9-tetrahydrocannabinol Acute Psychoactive Effects by Ranging Doses of Cannabidiol in Healthy, Occasional Cannabis Users: a Controlled, Triple Blind, Randomized, Cross-over Study | NCT06099379 |
| A Study of the Abuse Potential of Dronabinol in Recreational Cannabinoid Users | A Single-dose, Double-blind, Double-dummy, Randomized, Placebo- and Active-controlled Crossover Study to Evaluate the Abuse Potential of Dronabinol Oral Solution in Recreational Cannabinoid Users | NCT02094599 |
| A phase II randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of an oral solution of 9-? tetrahydrocannabinol/cannabidiol (THC/CBD) in multiple sclerosis patients with chronic neuropathic pain | A phase II randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of an oral solution of 9-? tetrahydrocannabinol/cannabidiol (THC/CBD) in multiple sclerosis patients with chronic neuropathic pain - BLCL-THC/CBD-01 | CTIS2024-520287-34-01 |
| Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea | Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial | NCT01755091 |
| The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol | The Pharmacokinetics of Oral Tetrahydrocannabinol and Cannabidiol Across the Spectrum of Glomerular Filtration Rate: a PharmacoKinetic Study | NCT05742724 |
| Clinical study to investigate the efficacy and safety of the test substance BX-1 (dronabinol) for the symptomatic relief of spasticity in patients with multiple sclerosis | A phase III, multi-centre, randomised, double-blind, placebo-controlled, parallel-group clinical trial to investigate the efficacy and safety of BX-1 for the symptomatic relief of spasticity in patients with multiple sclerosis - BX-1 in spasticity due to MS | EUCTR2018-000001-23-HU |
| Dronabinol Opioid Sparing Evaluation (DOSE) Trial | Dose-Titration Study to Evaluate the Opioid-Sparing Effect of Dronabinol When Coadministered With Opioid Analgesics to Chronic Pain Patients | NCT03766269 |
| Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia | Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia | NCT01598896 |
| Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions | A Single-Dose, Replicate Crossover Design Comparative Bioavailability Study of Dronabinol Oral Solution 5 mg Versus Marinol Capsules 5 mg Under Fasted Conditions | NCT01448772 |
| Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain | Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain | NCT02569073 |
| Dronabinol as an Adjunct for Reducing Pain | A Randomized, Double-Blind, Placebo-Controlled, Parallel Groups Study to Explore the Safety and Therapeutic Potential of Dronabinol as an Adjunct for Reducing Pain | NCT06454669 |
| Effect of delta-9-tetrahydrocannbinol (THC) on obstructive sleep apnoea and the mechanisms which cause it. | Effect of delta-9-tetrahydrocannabinol on obstructive sleep apnoea severity and its pathophysiological contributors in adults aged 25-70 years. | ACTRN12625000573459 |
| Effects of Dronabinol (Oral THC) on Cannabis Use | Effects of Dronabinol (Oral THC) on Cannabis Use | NCT01394185 |
| Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions | A Comparative Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions | NCT01380457 |
| The Effect of Tetrahydrocannabinol on Ocular Hemodynamics in Healthy Subjects | The Effect of Tetrahydrocannabinol on Ocular Hemodynamics in Healthy Subjects | NCT03907163 |
| CBD (Cannabidiol)/THC (Tetrahydrocannabinol) Solution as a Pharmacological Strategy for Patients With Fibromyalgia (FibroCann) | CBD/THC Solution as a Pharmacological Strategy for Patients With Fibromyalgia. Single-center, Double-blind, Randomized, Placebo-controlled Clinical Trial Protocol (FibroCann) | NCT05283161 |
| Delta-THC in Behavioral Disturbances in Dementia | Two Phase, Repeated Crossover Study With Dose Escalation on Delta(9)-Tetrahydrocannabinol (Delta-THC) in Behavioral Disturbances in Dementia | NCT01302340 |
| Marinol in Trichotillomania or Obsessive Compulsive Disorder | An Open-Label Study of Dronabinol, a Cannabinoid Agonist, for Obsessive Compulsive Disorder and the Obsessive-Compulsive Spectrum Disorders Trichotillomania and Pathological Skin Picking | NCT01093976 |
| Dronabinol Naltrexone Treatment for Opioid Dependence | Dronabinol Naltrexone Treatment for Opioid Dependence | NCT01024335 |
| Combined Pharmacotherapy for Cannabis Dependency | A Randomized, Double-Blind, Placebo-Controlled Study of Lofexidine and Dronabinol for the Treatment of Marijuana Dependence | NCT01020019 |
| Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Central Neuropathic Pain Related to Multiple Sclerosis | Multi-centre, Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Patients With Multiple Sclerosis Associated With Central Neuropathic Pain | NCT00959218 |
| Effects of dronabinol (Marinol(R)) on actual driving, simulated driving and Standardized Field Sobriety Test | Effects of dronabinol (Marinol(R)) on actual driving, simulated driving and Standardized Field Sobriety Test | EUCTR2009-014402-33-NL |
| Effect of pain medication on driving performance. | Effect of dronabinol on actual driving, simulated driving and the Standardized Field Sobriety Test. | NL-OMON26737 |
| Randomized Placebo-Controlled Crossover Trial With THC (Delta 9-Tetrahydrocannabinol) for the Treatment of Cramps in Amyotrophic Lateral Sclerosis (ALS) | Randomized Placebo-Controlled Crossover Trial With THC (Delta 9-Tetrahydrocannabinol) for the Treatment of Cramps in Amyotrophic Lateral Sclerosis (ALS) | NCT00812851 |
| Individual Differences in Drug Response | Differential Female Response to ?9-tetrahydrocannabinol (THC): The Influence of Estradiol | NCT03809546 |
| The effect of Tetrahydrocannabinol on ocular hemodynamics in healthy subjects | The effect of Tetrahydrocannabinol on ocular hemodynamics in healthy subjects - ONH Blood Flow THC | EUCTR2017-004852-52-AT |
| Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain | A Randomized, Cross-Over Controlled Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain | NCT02460692 |
| Proof of concept study on the combined effect of dronabinol and acetazolamide on apnoea hypopnoea index (AHI) in adults with obstructive sleep apnoea | Dose finding crossover trial investigating the effect of dronabinol combined with acetazolamide on Apnoea Hypopnea Index (AHI) in adults with obstructive sleep apnoea (OSA) | ACTRN12620000916943 |
| An Open Label Extension on the Examination of the Combination of Dronabinol and Acetazolamide for Treatment of Obstructive Sleep Apnoea (OSA) | An Open Label Extension study investigating the effect of dronabinol combined with acetazolamide administered for 6 months, on Apnoea Hypopnea Index (AHI) in adults with obstructive sleep apnoea (OSA) | ACTRN12621000809831 |
| Dronabinol On the Pain Experience | Dronabinol On the Pain Experience (DOPE): a Pragmatic Randomized Clinical Trial | NCT05820685 |
| The Effect of Dronabinol on the Acquisition and Consolidation of Trauma-Associated Memories | The Effect of Dronabinol on the Acquisition and Consolidation of Trauma-Associated Memories | NCT04871269 |
| Dronabinol in Total Knee Arthroplasty (TKA) | Effects of Perioperative Dronabinol Use in Total Knee Arthroplasty | NCT04734080 |
| Clinical study to investigate the efficacy and safety of the test substance BX-1 (dronabinol) for the symptomatic relief of spasticity in patients with multiple sclerosis | A phase III, multi-centre, randomised, double-blind, placebo-controlled, parallel-group clinical trial to investigate the efficacy and safety of BX-1 for the symptomatic relief of spasticity in patients with multiple sclerosis - BX-1 in spasticity due to MS | EUCTR2018-000001-23-CZ |
| The Effect of Dronabinol on Ocular Hemodynamics in Patients With Primary Open Angle Glaucoma | The Effect of Dronabinol on Ocular Hemodynamics in Patients With Primary | NCT04596826 |
| Effects of Delta9-tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R33 Study | Effects of THC on Retention of Memory for Fear Extinction Learning in PTSD: R33 Study | NCT04080427 |
| Can-ArtEffect and safety of using Canabis derivatives for the treatment of pain in patients with inflammatory Arthritis, such as reumatoid arthritis and ankylosing spondylitis, the latter being a type of arthritis that causes a long term inflammation of the joints of the spine. A randomized, double blinded, placebo controlled trial, i.e. in this drug trial, a control group is given a placebo while another group is given the Cannabis derivative being studied. | CAN-ARTThe efficacy and safety of using cannabis derivatives cannabidiol (CBD) and tetrahydrocannabinol (THC)for the treatment of pain in patients with inflammatory arthritis (RA, AS).A randomized, double blinded, placebo controlled trial - Can-Art | EUCTR2017-004226-15-DK |
| Dronabinol for Post-operative Pain After Lumbar Fusion | Impact of Dronabinol on Post-operative Pain After Lumbar Fusion for Degenerative Disorders of the Spine | NCT04346407 |
| Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors | A Double-Blind, Placebo-Controlled Study of Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors | NCT03530800 |
| Oral Dronabinol-HIV | Investigation of the Effects of Cannabis on the Immune-genome in People With HIV | NCT06034314 |
| BONG: Breathlessness and alternatives to Opioid treatment in Non-malign Groups of severe lung disease | BONG: Breathlessness and alternatives to Opioid treatment in Non-malign Groups of severe lung disease - Dronabinol in COPD patients | EUCTR2022-004238-20-DK |
| Effects of dronabinol on breathlessness and exercise capacity in chronic lung disease | Effects of dronabinol on dyspnea and quality of life in patients with chronic obstructive pulmonary disease: a randomized cross-over trial | ISRCTN66860544 |
| PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults | Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults | NCT05906511 |
| Dronabinol After Arthroscopic Surgery | Dronabinol for the Treatment of Postoperative Pain After Arthroscopic Surgery: a Pilot Randomized Trial | NCT05335252 |
| Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain | Dronabinol for the Reduction of Chronic Pain and Inflammation in People With Sickle Cell Disease | NCT05519111 |
| Investigating the Effect of Dronabinol on Post-surgical Pain | Investigating the Effect of Dronabinol on Post-surgical Pain | NCT04099355 |
| Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone | Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone | NCT02576912 |
| Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone: Sub-Study I | Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone: Sub-Study I | NCT02811939 |
| The effect of Tetrahydrocannabinol on ocular hemodynamics in patients with primary open angle glaucoma - A Phase II Study | The effect of Tetrahydrocannabinol on ocular hemodynamics in patients with primary open angle glaucoma- A Phase II Study - ONH Blood Flow THC Glaucoma | EUCTR2019-003089-42-AT |
| Dronabinol for Agitation in Dementia Crossover Trial | Single-site, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Dronabinol for the Treatment of Agitation in Outpatient With Dementia | NCT05612711 |
| A RCT Comparing Dronabinol to a Placebo for Post-operative Pain in Total Joint Arthroplasty | A Prospective, Randomized, Double Blind Trial Comparing Dronabinol to a Placebo in the Management of Post-operative Pain in Total Joint Arthroplasty | NCT04298528 |
